Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
11/2005
11/17/2005US20050257278 Transgenic non-human animals expressing a truncated activin type II receptor
11/17/2005US20050257277 Regulation of transcription with a cis-acting ribozyme
11/17/2005US20050257276 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/17/2005US20050256044 Gastrointestinal proliferative factor and uses thereof
11/17/2005US20050256036 Gastrointestinal proliferative factor and uses thereof
11/17/2005US20050255573 An in vitro method of maintaining a mouse or human pluripotent cell in a pluripotent state by increasing expression of a gene that encodes a factor which acts intracellularly and maintainspluripotency, where the factor is a polypeptide of the sequence of SEQ ID NO: 4; cultures
11/17/2005US20050255550 Suppression of xenotransplant rejection
11/17/2005US20050255549 IRAK-4: compositions and methods of use
11/17/2005US20050255087 Adeno-associated virus vectors
11/17/2005DE10361328B3 Anordnung zur Zucht von Insekten Arrangement for the breeding of insects
11/17/2005CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/16/2005EP1595447A1 Transgenic animal having fatty acid desaturase and method of producing the same
11/16/2005EP1594988A2 Method of diagnosis of type 2 diabetes and early onset thereof
11/16/2005EP1594892A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
11/16/2005CN2739970Y Automatic fly collecter
11/16/2005CN1695441A Method for breeding multiparous new strain of meaty goat
11/16/2005CN1695440A Method for breeding multiparous new strain of goat
11/16/2005CN1695439A Method for breeding chicken and feeds utilized thereof
11/15/2005US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods
11/15/2005US6964856 Monitoring progress of infection in animals after exposure to microbiocides; drug screening
11/15/2005US6964853 Smad6 and uses thereof
11/10/2005WO2005106473A1 Method of screening therapeutic agent for neurodegenerative disease
11/10/2005WO2005106028A1 Method of identifying target of compound acting on natural immunity
11/10/2005WO2005104840A1 Entomopathogenic nematodes and methods of their use
11/10/2005WO2005104836A2 Drosophila models for diseases affecting learning and memory
11/10/2005WO2005104835A2 Transgenic animals and uses thereof
11/10/2005WO2005104834A2 Pain-associated gene pnpg5
11/10/2005WO2005104833A1 Method of constructing animal model suffering from left ventricular diastolic disorder for examining heart failure and method of examining remedy for heart failure caused by left ventricular diastolic failure with the use of the animal model
11/10/2005WO2004050898A3 Ampk pathway components
11/10/2005US20050251874 Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels
11/10/2005US20050251873 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/10/2005US20050251872 Lentiviral vectors, related reagents, and methods of use thereof
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050251870 Csnk1gs as modifiers of the p21 pathway and methods of use
11/10/2005US20050251869 Animal model for raising HDL-cholesterol with niacin
11/10/2005US20050250720 Novel compound
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050249711 Allogeneic vaccine and methods to synthesize same
11/10/2005CA2565068A1 Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof
11/10/2005CA2565022A1 Entomopathogenic nematodes and methods of their use
11/10/2005CA2564513A1 I-dmoi derivatives with enhanced activity at 37·c and use thereof
11/10/2005CA2564231A1 Method of constructing animal model suffering from left ventricular diastolic disorder for examining heart failure and method of examining remedy for heart failure caused by left ventricular diastolic failure with the use of the animal model
11/10/2005CA2563064A1 Transgenic animals and uses thereof
11/09/2005EP1593740A1 Method of screening anti-obestic medicine, and obesity model animal
11/09/2005EP1592789A2 Administration of transposon-based vectors to reproductive organs
11/09/2005EP1592773A2 Exogenous proteins expressed in avians and their eggs
11/09/2005EP1592647A1 Composter
11/09/2005EP1546327A4 Selection and isolation of living cells using rna-binding probes
11/09/2005EP1423516B1 Identification of eukaryotic internal ribosome entry site (ires) elements
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1111048B1 Neutral amino acid transporter and gene thereof
11/09/2005EP0939769B1 Vertebrate smoothened proteins
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694894A Anti-IL-6 antibodies, compositions, methods and uses
11/09/2005CN1692717A Method and apparatus for application of chemicals to insect, and use for selecting medicine in large scale therewith
11/08/2005US6962975 from transgenic mouse brains, for infection of humans, cows, and sheep; for bioassay
11/08/2005US6962804 Generating modified fly flippase recombination target sequences to act as site of genetic exchange during transposon-induced mutagenesis
11/03/2005WO2005103694A2 Methods and fish models for identifying agents for treating bone and joint disease
11/03/2005WO2005103265A1 Multiple heat shock elements
11/03/2005WO2005103246A1 Human retrovirus-sensitive transgenic nonhuman animal cell and human retrovirus-sensitive transgenic nonhuman animal model
11/03/2005WO2005103229A2 Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using
11/03/2005WO2005102368A1 Method for the biodegradation of protein- and/or fat-rich materials
11/03/2005WO2005102041A2 Crustacean expression vector
11/03/2005WO2005102040A1 Tlr ligand and il-1 response-injured animal model
11/03/2005WO2005102039A1 Human retrovirus-sensitive transgenic nonhuman animal cell and human retrovirus-sensitive transgenic nonhuman animal model
11/03/2005WO2005102038A2 Expression of polypeptides in rod outer segment membranes
11/03/2005WO2005101956A2 Method of identifying therapeutic compounds which can be used for the treatment and/or prevention of infections and diseases caused by human herpesviruses
11/03/2005WO2005085472A3 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
11/03/2005WO2005084691B1 Method of proliferating precursor cells
11/03/2005WO2004032610A3 The isolation, culture, and use of marine copepods in aquaculture
11/03/2005WO2003062173A8 Alanine 2,3- aminomutase
11/03/2005US20050246783 Microinjection devices and methods of use
11/03/2005US20050246782 Transgenic aves producing human polyclonal antibodies
11/03/2005US20050246781 Transgenic production in saliva
11/03/2005US20050246780 Phytases, nucleic acids encoding them and methods for making and using them
11/03/2005US20050246566 Process for providing submodel performance in a computer processing unit
11/03/2005US20050245450 Method of screening a compound for anxiolytic activity in an apolipoprotein E knockout animal
11/03/2005US20050245444 Method of using recombinant human antithrombin for neurocognitive disorders
11/03/2005US20050244970 Stem cell libraries
11/03/2005US20050244411 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244387 Entomopathogenic nematodes and methods of their use
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244381 Adenovirus including a gene coding for a superoxide dismutase
11/03/2005US20050241590 Metamorphosizing gift item and method of gift-giving which utilizes the life-cycle of a living being
11/03/2005CA2563614A1 Tlr ligand and il-1 response-injured animal model
11/03/2005CA2562787A1 Method of identifying therapeutic compounds which can be used for the treatment and/or prevention of infections and diseases caused by human herpesviruses
11/02/2005EP1590663A2 Immunocompromised rodents as dual color tumor models
11/02/2005EP1590661A2 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders
11/02/2005EP1590468A2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/02/2005EP1590467A1 Use of regulatory sequences for specific, transient expression in neuronal determined cells
11/02/2005EP1590461A1 Ires
11/02/2005EP1590453A2 Custom-made meganuclease and use thereof
11/02/2005EP1590435A2 Depletion of endogenous primordial germ cels in avian species
11/02/2005EP1590363A2 Bh3 peptides and method of use thereof
11/02/2005EP1589980A2 Methods of diagnosis and treatment of interstitial lung disease
11/02/2005EP1183355B1 T-bet compositions and methods of use thereof
11/02/2005CN2737145Y Ediable easily silkworm chrysalis food